Perspectives magazine is an annual glossy supporting the Mount Sinai Hospital Auxiliary, Mount Sinai Hospital and the Samuel Lunenfeld Research Institute.
Issue link: http://read.uberflip.com/i/605382
SHS News S I N A I H EA LT H SY ST E M W E LCOM E S N E W H EA D O F GY N A ECO LO GY A N D M I N I M A L LY I N VA S I V E S U RG E RY In his new role as head of Gynaecology and Minimally Invasive Surgery at Mount Sinai Hospital, Dr. Jonathon Solnik will focus on expanding the program and offering minimally invasive surgical options for gynaecologic conditions that allow for faster recovery times and lower risks of complications and infections for patients. A Toronto native, Dr. Solnik is an established leader in his field. He previously served as Division Director of Urogynaecology and the Center of Excellence for Minimally Invasive Surgery at Los Angeles' Cedars-Sinai Medical Centre, where he was recognized by US News & World Report: Health in its 'Best Doctors in America' and 'Best Doctors in Los Angeles' reports. D R . DA N I E L D R U C K E R N A M E D TO T H E O R D E R O F C A N A DA In recognition of his transformative discoveries and contributions, Dr. Daniel Drucker, one of Canada's foremost diabetes researchers, was named an Officer of the Order of Canada. A senior investigator at the Lunenfeld-Tanenbaum Research Institute (LTRI), Dr. Drucker conducts research that encompasses a full spectrum of science from discovery through to clinical care. He is internationally renowned for conducting the research that led to the development of two new classes of therapies for the treatment of type 2 diabetes and a new therapy for patients with short bowel syndrome, benefitting millions of patients worldwide. D R . DA N I E L D U RO C H E R I S S ECO N D LT R I R E S EA RC H E R TO R EC E I V E PAU L M A R K S P R I Z E F ROM M E MO R I A L S LOA N K ETT E R I N G C A N C E R C E N T E R Dr. Daniel Durocher, Thomas Kierans Research Chair in Mechanisms of Cancer Development and assistant director of the Lunenfeld-Tanenbaum Research Institute, has been selected as one of three winners of this year's Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center in New York City. Dr. Durocher is being recognized for his research on how cells maintain the integrity of their genomes, and how cells repair and respond to a particular type of damage called the DNA double-strand break, which can lead to chromosome rearrangements and mutations that cause cancer. Much of his recent research has focused on how the BRCA1 protein helps cells respond to DNA damage. Dr. Durocher is the second researcher from the LTRI to receive the prize; in 2005, it was awarded to Dr. Jeff Wrana, CIBC Scientist in Breast Cancer Research and the Mary Janigan Research Chair in Molecular Cancer Therapeutics. 2